Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 24, 2024

BUY
$25.26 - $29.6 $88,687 - $103,925
3,511 New
3,511 $98,000
Q3 2023

Oct 19, 2023

BUY
$32.09 - $37.51 $770 - $900
24 Added 0.17%
13,990 $464,000
Q2 2023

Aug 08, 2023

BUY
$36.12 - $41.79 $614 - $710
17 Added 0.12%
13,966 $512,000
Q1 2023

May 01, 2023

BUY
$39.39 - $51.28 $354 - $461
9 Added 0.06%
13,949 $569,000
Q4 2022

Feb 07, 2023

SELL
$41.75 - $54.5 $249,832 - $326,128
-5,984 Reduced 30.03%
13,940 $714,000
Q3 2022

Nov 15, 2022

BUY
$43.76 - $53.42 $701,735 - $856,643
16,036 Added 412.45%
19,924 $872,000
Q2 2022

Dec 01, 2022

SELL
$46.53 - $55.17 $65,607 - $77,789
-1,410 Reduced 7.08%
18,514 $971,000
Q1 2022

Nov 30, 2022

SELL
$45.75 - $56.69 $727,699 - $901,711
-15,906 Reduced 79.83%
4,018 $208,000
Q4 2021

Feb 02, 2022

BUY
$41.32 - $61.25 $160,652 - $238,140
3,888 New
3,888 $230,000
Q3 2019

Nov 12, 2019

SELL
$32.49 - $42.13 $178,175 - $231,040
-5,484 Closed
0 $0
Q2 2019

Aug 06, 2019

BUY
$36.98 - $41.52 $295 - $332
8 Added 0.15%
5,484 $238,000
Q1 2019

May 06, 2019

SELL
$37.5 - $41.2 $28,200 - $30,982
-752 Reduced 12.07%
5,476 $233,000
Q4 2018

Feb 05, 2019

BUY
$38.47 - $43.86 $269 - $307
7 Added 0.11%
6,228 $272,000
Q3 2018

Oct 31, 2018

SELL
$34.47 - $41.81 $2,585 - $3,135
-75 Reduced 1.19%
6,221 $274,000
Q2 2018

Aug 03, 2018

SELL
$32.98 - $35.16 $23,745 - $25,315
-720 Reduced 10.26%
6,296 $228,000
Q1 2018

Apr 26, 2018

SELL
$31.91 - $37.02 $60,182 - $69,819
-1,886 Reduced 21.19%
7,016 $249,000
Q4 2017

Feb 07, 2018

BUY
$33.26 - $35.29 $598 - $635
18 Added 0.2%
8,902 $322,000
Q3 2017

Nov 07, 2017

SELL
$31.0 - $34.15 $1,767 - $1,946
-57 Reduced 0.64%
8,884 $317,000
Q2 2017

Aug 08, 2017

BUY
N/A
8,941
8,941 $300,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $149B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Family Firm, Inc. Portfolio

Follow Family Firm, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Family Firm, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Family Firm, Inc. with notifications on news.